2019-04-01
Legal Press releases
Update of previous Press Release distributed April 1, 2019: Contact information for Certified Adviser added. Otherwise no changes.
The biotechnology company Intervacc has together with 3P ... Read more
2019-04-01
Legal Press releases
The biotechnology company Intervacc has together with 3P Biopharmaceuticals, the contracted manufacturer of Strangvac, secured large-scale production of the vaccine against equine strangles. The technology transfer of ... Read more
2018-12-12
Legal Press releases
Intervacc, a Swedish innovative vaccine company listed on Nasdaq First North, has appointed Andreas Andersson as CEO. The Company thus gains a valuable addition to lead the expansion and strategic development on the ... Read more
2018-10-15
Legal Press releases
The Swedish biotechnology company Intervacc has now taken another step towards confirming the effect of its vaccine, one of the company's development development projects, against the infamous streptococcal infection ... Read more
2018-07-12
Legal Press releases
Intervacc has been awarded funding through the Eurostars-2 program for further development of a vaccine against severe infection of piglets caused by Streptococcus suis. The Eurostars-2 program, a part of EU:s ... Read more
2018-07-09
Legal Press releases
Strangvac® is Intervacc's vaccine against strangles, which is a very severe and contagious infection in the horse. Intervacc has previously signed an agreement with 3P Biopharmaceuticals in Pamplona, Spain for large-scale commercial ... Read more